{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:50:40Z","timestamp":1790398240162,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.ophtha.2004.05.028","type":"journal-article","created":{"date-parts":[[2004,12,10]],"date-time":"2004-12-10T14:36:13Z","timestamp":1102689373000},"page":"2232-2239","source":"Crossref","is-referenced-by-count":73,"title":["Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy"],"prefix":"10.1016","volume":"111","author":[{"given":"Douglas A.","family":"Jabs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark L.","family":"Van Natta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David V.","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis A.","family":"Meredith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baruch D.","family":"Kuppermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent","family":"Sepkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen K.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2004.05.028_bib1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2004.05.028_bib2","doi-asserted-by":"crossref","first-page":"570","DOI":"10.7326\/0003-4819-130-7-199904060-00005","article-title":"Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression","volume":"130","author":"Miller","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ophtha.2004.05.028_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7326\/0003-4819-135-1-200107030-00005","article-title":"Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease","volume":"135","author":"Murphy","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ophtha.2004.05.028_bib4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.7326\/0003-4819-133-6-200009190-00007","article-title":"Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy","volume":"133","author":"Grabar","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ophtha.2004.05.028_bib5","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.286.20.2560","article-title":"HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load","volume":"286","author":"Phillips","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ophtha.2004.05.028_bib6","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1001\/jama.286.20.2568","article-title":"Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy","volume":"286","author":"Hogg","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ophtha.2004.05.028_bib7","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nm0898-953","article-title":"Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1","volume":"4","author":"Komanduri","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.ophtha.2004.05.028_bib8","doi-asserted-by":"crossref","unstructured":"Kaplan JE, Masur H, Holmes KK, U.S. Public Health Service, Infectious Diseases Society of America. Guidelines for preventing opportunistic infections among HIV-infected persons-2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep 2002;51(RR-8):1\u201352.","DOI":"10.7326\/0003-4819-137-5_Part_2-200209031-00002"},{"key":"10.1016\/j.ophtha.2004.05.028_bib9","first-page":"623","article-title":"Ocular manifestations of HIV infection","volume":"93","author":"Jabs","year":"1995","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ophtha.2004.05.028_bib10","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/infdis\/166.6.1223","article-title":"Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine","volume":"166","author":"Gallant","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ophtha.2004.05.028_bib11","first-page":"1069","article-title":"Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus","volume":"5","author":"Pertel","year":"1992","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ophtha.2004.05.028_bib12","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/archopht.1996.01100140035004","article-title":"Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression","volume":"114","author":"Hoover","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.028_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0002-9394(14)70789-5","article-title":"AIDS and ophthalmology","volume":"124","author":"Jabs","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.028_bib14","first-page":"1931","article-title":"Decline in the rate of specific opportunistic infections at San Francisco General Hospital 1994-1997","volume":"12","author":"Holtzer","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.ophtha.2004.05.028_bib15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1086\/313612","article-title":"Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy","volume":"30","author":"Jacobson","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ophtha.2004.05.028_bib16","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0002-9394(98)00285-2","article-title":"Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy","volume":"126","author":"Jabs","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.028_bib17","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1086\/517399","article-title":"Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus\u2013infected patients","volume":"177","author":"Tural","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ophtha.2004.05.028_bib18","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1086\/515281","article-title":"Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy","volume":"177","author":"Macdonald","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ophtha.2004.05.028_bib19","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1001\/jama.282.17.1633","article-title":"Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis","volume":"282","author":"Whitcup","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ophtha.2004.05.028_bib20","doi-asserted-by":"crossref","unstructured":"Jabs DA, Van Natta ML, Thorne JE, et al, Studies of Ocular Complications of AIDS Research Group. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progression. Ophthalmology 2004;111:2224\u20132224.e3.","DOI":"10.1016\/j.ophtha.2004.05.031"},{"key":"10.1016\/j.ophtha.2004.05.028_bib21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/archopht.1989.01070010077031","article-title":"Cytomegalovirus retinitis and acquired immunodeficiency syndrome","volume":"107","author":"Jabs","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.028_bib22","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0161-6420(94)31181-X","article-title":"Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial 4. Visual outcomes","volume":"101","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2004.05.028_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/archopht.1996.01100130021004","article-title":"Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS","volume":"114","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.028_bib24","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/archopht.1997.01100160698006","article-title":"MSL-109 adjuvant therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndromeThe Monoclonal Antibody Cytomegalovirus Retinitis Trial","volume":"115","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.028_bib25","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1001\/archopht.118.9.1196","article-title":"Risk factors for advancement of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome","volume":"118","author":"Holbrook","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.028_bib26","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1001\/archopht.1991.01080060058024","article-title":"Retinal detachments in patients with cytomegalovirus retinitis","volume":"109","author":"Jabs","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.028_bib27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0002-9394(14)71645-9","article-title":"Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis","volume":"124","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.028_bib28","first-page":"33","article-title":"Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome","volume":"119","author":"Kempen","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.028_bib29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0002-9394(01)01322-8","article-title":"Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy","volume":"133","author":"Jabs","year":"2002","journal-title":"Am J Ophthalmol"},{"issue":"RR-17","key":"10.1016\/j.ophtha.2004.05.028_bib30","first-page":"1","article-title":"1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults","volume":"41","author":"Castro","year":"1992","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ophtha.2004.05.028_bib31","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L","article-title":"The use of the nitrogen mustards in the palliative treatment of carcinoma","volume":"1","author":"Karnofsky","year":"1948","journal-title":"Cancer"},{"key":"10.1016\/j.ophtha.2004.05.028_bib32","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1128\/JCM.37.5.1431-1435.1999","article-title":"Comparison of cytomegalovirus loads in plasma and leukocytes of patients with cytomegalovirus retinitis","volume":"37","author":"Jabs","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ophtha.2004.05.028_bib33","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0002-9394(00)00356-1","article-title":"Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis following highly active antiretroviral therapy","volume":"129","author":"Nguyen","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.028_bib34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc Ser B Stat Method"},{"key":"10.1016\/j.ophtha.2004.05.028_bib35","series-title":"Statistical Methods in Medical Research","author":"Armitage","year":"1987"},{"key":"10.1016\/j.ophtha.2004.05.028_bib36","unstructured":"SAS\/STAT User's Guide. Version 8.0. Cary, NC: SAS Publishing; 2000."},{"key":"10.1016\/j.ophtha.2004.05.028_bib37","unstructured":"Stata Statistical Software [computer program]. Release 6.0. College Station, TX: Stata Corp.; 1999."},{"key":"10.1016\/j.ophtha.2004.05.028_bib38","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1086\/339603","article-title":"Comparison of cytomegalovirus (CMV) UL97 gene sequences in the blood and vitreous of patients with acquired immunodeficiency syndrome and CMV retinitis","volume":"185","author":"Hu","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ophtha.2004.05.028_bib39","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/archopht.1994.01090240037023","article-title":"Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial","volume":"112","author":"Martin","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.028_bib40","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/infdis\/175.2.302","article-title":"Utility of urine and leukocyte cultures and plasma DNA polymerase chain reaction for identification of AIDS patients at risk for developing human cytomegalovirus disease","volume":"175","author":"Shinkai","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ophtha.2004.05.028_bib41","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.1128\/JVI.73.8.7027-7030.1999","article-title":"Cytomegalovirus (CMV) DNA load is an independent predictor of CMV disease and survival in advanced AIDS","volume":"73","author":"Spector","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.ophtha.2004.05.028_bib42","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1056\/NEJM199904083401402","article-title":"Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant","volume":"340","author":"Martin","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2004.05.028_bib43","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00006982-199911000-00002","article-title":"Removal of silicone oil with vision improvement after rhegmatogenous retinal detachment following CMV retinitis in patients with AIDS","volume":"19","author":"Schaller","year":"1999","journal-title":"Retina"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642004009273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642004009273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T07:16:57Z","timestamp":1734765417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642004009273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0161642004009273"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2004.05.028","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}